
Avelumab Uses, Side Effects & Warnings - Drugs.com
Avelumab is used to treat a type of skin cancer called Merkel cell carcinoma in adults and children at least 12 years old, when the cancer has spread to other parts of the body (metastatic). …
Avelumab - Wikipedia
Avelumab, sold under the brand name Bavencio, is a fully human monoclonal antibody medication for the treatment of Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma. [5]
Avelumab Injection: MedlinePlus Drug Information
Avelumab injection is used to treat Merkel cell carcinoma (MCC; a type of skin cancer) that has spread to other parts of the body in adults and children 12 years of age and older.
Avelumab - NCI - National Cancer Institute
2017年4月1日 · Avelumab is a type of drug called an immune checkpoint inhibitor. It works by binding to the protein PD-L1 on the surface of some cancer cells, which keeps cancer cells …
FDA approves avelumab for urothelial carcinoma maintenance …
On June 30, 2020, the Food and Drug Administration approved avelumab (BAVENCIO, EMD Serono, Inc.) for maintenance treatment of patients with locally advanced or metastatic …
Avelumab Solution - Uses, Side Effects, and More - WebMD
Avelumab is used to treat various types of cancer. It works by changing the action of your own immune system, directing it to attack cancer cells. Avelumab belongs to a class of drugs …
Avelumab: Uses, Interactions, Mechanism of Action - DrugBank …
Avelumab is an anti-PD-L1 monoclonal antibody used to treat metastatic merkel cell carcinoma, metastatic urothelial carcinoma, or renal cell carcinoma.
Avelumab (intravenous route) - Mayo Clinic
2025年3月1日 · Avelumab injection is used to treat a kind of skin cancer called Merkel cell carcinoma (MCC) that has spread. Avelumab injection is also used to treat urothelial …
Drug Formulary - Cancer Care Ontario
Find documents on drug safety and administration for healthcare providers, including calculations and recommendations.
Product review: avelumab, an anti-PD-L1 antibody - PMC
Avelumab is a fully human monoclonal antibody that blocks the interaction between PD-L1 on tumor cells and PD-1 on T cells, thereby inhibiting immunosuppression in the tumor …